ArticleJournal for immunotherapy of cancer2023

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy.

Natalia Plewa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.